Please use this identifier to cite or link to this item: http://buratest.brunel.ac.uk/handle/2438/7784
Title: Raising the bar for market authorisation of new drugs
Authors: Naci, H
Cylus, J
Vandoros, S
Sato, A
Perampaladas, K
Keywords: Drug approval;Drug discovery;Drug industry;Europe;Evidence-based medicine;Drug legislation;Marketing of health services;Treatment outcome;United States;United States Food and Drug Administration
Issue Date: 2012
Publisher: BMJ Publishing Group
Citation: BMJ, 345, e4261, 2012
Description: © BMJ Publishing Group Ltd 2012
URI: http://www.ncbi.nlm.nih.gov/pubmed/22872693
http://bura.brunel.ac.uk/handle/2438/7784
DOI: http://dx.doi.org/10.1136/bmj.e4261
ISSN: 0959-8138
Appears in Collections:Economics and Finance
Community Health and Public Health
Dept of Economics and Finance Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf232.23 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.